期刊文献+

转染B7-1基因的Raji和Jurkat细胞诱导细胞因子mRNA表达的研究 被引量:3

Study on Expression of Cytokines mRNA Induced by B7-l-transfected Raji and Jurkat Cells
下载PDF
导出
摘要 为探讨B7共刺激分子在T细胞活化和分化中的作用,利用脂质体介导的转基因技术将B7基因导入恶性血液病细胞系Raji和Jurkat细胞,用流式细胞术检测转基因前、后B7-1基因的表达,用RT-PCR检测T细胞表面细胞因子IL-2,IL-4和IFN-γ mRNA的表达及这3种细胞因子在转基因后4,12,20及48小时的时间动态变化。结果发现,B7^+ Raji细胞可诱导T细胞分泌细胞因子IL-2,IL-4和IFN-γ,B7^+ Jurkat细胞可诱导IL-2和IFN-γ的分泌,而B7^- Raji细胞及B7^- Jurkat细胞均未诱导细胞因子的分泌。IL-2和IL-4在T细胞活化4小时即可检测到,IFN-γ在T细胞活化12小时可检测到,在20小时出现峰值。结论:B7-1基因的导入可有效地增强肿瘤细胞的免疫原性,激活T细胞,B7-1在T细胞活化和分化中起着更主要的作用。 To investigate the function of B7 co-stimulator in activation and differentiation of T cell,B7 gene was transfected into Raji and Jurkat cells by liposome,B7 expression in tumor cells was detected with flow cytometry,and expression of IL-2,IL-4 and IFN-ymRNA was detected by RT-PCR.Kinetics of secretion of three cytokines were also analyzed at 4,12,20 and 48 hours after gene transfection.The results showed that B7+ Raji cells could induce mRNA expression of IL-2,IL-4 and IFN-y on T cell surface; B7+ Jurkat cells could induce secretion of IL-2 and IFN-y.However,B7 Raji and B7 Jurkat cells could not induce secretion of cytokines.Kinetics of the three cytokines secretion were different,IL-2 and IL-4 were only detectable after 4 hours of T cell activation,whereas IFN-y was detectable after 12 hours of stimulation.The peak levels of IL-2,IL-4 and IFN-y were found at 20 hours after activation.It was concluded that tumor cell lines transfected B7 gene could enhance their immunocompetence,activating T cell efficiently and B7-1 play more critical role in T cell activation and differentiation.
出处 《中国实验血液学杂志》 CAS CSCD 2002年第4期322-326,共5页 Journal of Experimental Hematology
基金 国家自然科学基金 编号 39770328
关键词 B7-1基因 基因转染 T细胞 细胞因子 Raji细胞系 Jurkat细胞系 恶性血液病 B7-1 gene gene transfection T cell cytokine Raji cell line Jurkat cell line
  • 相关文献

参考文献9

  • 1Boussiotis VA, Freeman GJ, Gray G, et al. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. J Exp Med, 1993; 178:1753- 1763
  • 2Bretscher P. The two-signal model of lymphocyte activation twenty one years later. Immunol Today, 1992; 13:74-76
  • 3Freeman GJ, Boussiotis VA, Anumanthan A, et al. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7 1 preferentially costimulates the initial production of IL-4. Immunity, 1995; 2:523- 532
  • 4Mueller DL, Jenkine MK, Schwartz RH. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway de termines the outcome of T cell antigen receptor occupancy. AnnuRev Immunol, 1989; 7:445 - 480
  • 5Kuchroo VK, Martin CA, Greer JM, et al. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-spe cific T cell clones to mediate experimental allergic encephalomyelitis. J Immunol, 1993; 151:4371-4382
  • 6Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA, 1994; 91:8562- 8566
  • 7J@萨姆布鲁克,EF弗里奇,T曼尼阿蒂斩主编(金冬雁,黎孟枫等译).分子克隆实验指南.第一版.北京:科学出版社,1992:24-27,55-56
  • 8Heuer JG, Tucker-McClung C, Gonin R, et al. Retrovirus-mediated gene transfer of B7-1 and MHC class Ⅱ converts a poorly immunogenic neuroblastoma into a highly immunogenic one. Hum Gene Ther, 1996; 7:2059- 2068
  • 9Paliard X, De Waal Malefijt R, Yssel H, et al. Simultaneous pro ductionof IL-2, IL-4, and IFN-γ by activated human CD4+ and CD8+ T cell clones. J Immunol, 1988; 141:849-855

同被引文献34

  • 1王凯,彭建强,袁振华,吴小兵.AD5/F35腺病毒载体对不同来源造血系统恶性细胞转染效率的研究[J].中国实验血液学杂志,2006,14(3):525-528. 被引量:6
  • 2Zhou ZF, Peretz Y, Chang Y, et al.Intramuscular gene transfer of soluble B7. 1/IgG( 1 ) fusion cDNA induces potent antitumor immunity as an adjuvant for DNA vaccination. Cancer Gene Ther, 2003 ; 10 : 491 - 499
  • 3Stopeck AT , Jones A , Hersh EM , et al, Phase Ⅱ study of direct intralesional gene transfer of allovectin 27, an HLA-B7/beta 2-microglobulin DNA-liposome complex , in patients with metastatic melanoma. Clin Cancer Res, 2001 ; 7 :2285 - 2291
  • 4Vasilevko V , Ghochikyan A , Sadzikava N , et al.Immunization with a vaccine that combines the expression of MUC1 and B7 costimulatory molecules prolongs the survival of mice and delays the appearance of mouse mammary tumors. Clin Exp Metastasis, 2003 ; 20:489 -498
  • 5Morioka J , Kajiwara K, Yoshikawa K, et al. Vaccine therapy for murine glioma using tumor cells genetically modified to express B7.1. Neurosurgery, 2004; 54:182 - 189
  • 6Tsuji H, Kawaguchi S, Wada T, et al. Adenovirus-mediated in vivo B7-1 gene transfer induces anti-tumor immunity against pre-established primary tumor and pulmonary metastasis of rat osteosarcoma. Cancer Gene Ther, 2002 ; 9:747 - 755
  • 7Raez LE, Cassileth PA , Schlesselman JJ , et al.Allogeneic vaccination with a B7. 1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small-cell lung cancer. J Clin Oncol, 2004 ; 22 : 2800 - 2807
  • 8Kimura T, Ohashi T, Kikuchi T, et al.Antitumor immunity against bladder cancer induced by ex vivo expression of CD40 ligand gene using retrovirus vector. Cancer Gene Therapy, 2003 ;10 : 833 - 839
  • 9Briones J, Timmerman J, Levy R. in vivo antitumor effect of CD40L-transduced tumor cells as a vaccine for B-cell lymphomal. Cancer Res, 2002 ; 62 : 3195 - 3199
  • 10Tangney M, Casey G, Larkin JO, et al.Non-viral in vivo immune gene therapy of cancer: combined strategies for treatment of systemic disease . Cancer Immunol Immunother, 2006; 55:1443 - 1450

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部